USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA

USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA

The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of sc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANDOR, GYOERGY, LASZLOVSZKY, ISTVAN, NEMETH, GYOERGY
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANDOR, GYOERGY
LASZLOVSZKY, ISTVAN
NEMETH, GYOERGY
description The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. La présente invention concerne l'utilisation de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique, dans la fabrication d'un médicament destiné au traitement de la schizophrénie. La présente invention concerne également le traitement de la schizophrénie par administration de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2687521C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2687521C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2687521C3</originalsourceid><addsrcrecordid>eNqFjb0KwjAYRbs4iPoMZlToN_THnzXGryaQJiWNYCpSisRJtFA3cfDNLeLudLhwuGcYvPclEp0Ra6gqIYVnDMcUZnGYwFYwLrXRBUfl5BwKUaChlVAQgZMnQMudfIEKVa_m38Wo2dBcOwnMMak5HpykuVBIMm36BlIr1I6UjIuq_zWoBB0Hg0tz7fzkx1EwzdAyDr69175rm7O_-UfNaLxcrxZxxJL_xgfLMjv8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA</title><source>esp@cenet</source><creator>ANDOR, GYOERGY ; LASZLOVSZKY, ISTVAN ; NEMETH, GYOERGY</creator><creatorcontrib>ANDOR, GYOERGY ; LASZLOVSZKY, ISTVAN ; NEMETH, GYOERGY</creatorcontrib><description>The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. La présente invention concerne l'utilisation de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique, dans la fabrication d'un médicament destiné au traitement de la schizophrénie. La présente invention concerne également le traitement de la schizophrénie par administration de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150623&amp;DB=EPODOC&amp;CC=CA&amp;NR=2687521C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150623&amp;DB=EPODOC&amp;CC=CA&amp;NR=2687521C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANDOR, GYOERGY</creatorcontrib><creatorcontrib>LASZLOVSZKY, ISTVAN</creatorcontrib><creatorcontrib>NEMETH, GYOERGY</creatorcontrib><title>USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA</title><description>The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. La présente invention concerne l'utilisation de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique, dans la fabrication d'un médicament destiné au traitement de la schizophrénie. La présente invention concerne également le traitement de la schizophrénie par administration de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjb0KwjAYRbs4iPoMZlToN_THnzXGryaQJiWNYCpSisRJtFA3cfDNLeLudLhwuGcYvPclEp0Ra6gqIYVnDMcUZnGYwFYwLrXRBUfl5BwKUaChlVAQgZMnQMudfIEKVa_m38Wo2dBcOwnMMak5HpykuVBIMm36BlIr1I6UjIuq_zWoBB0Hg0tz7fzkx1EwzdAyDr69175rm7O_-UfNaLxcrxZxxJL_xgfLMjv8</recordid><startdate>20150623</startdate><enddate>20150623</enddate><creator>ANDOR, GYOERGY</creator><creator>LASZLOVSZKY, ISTVAN</creator><creator>NEMETH, GYOERGY</creator><scope>EVB</scope></search><sort><creationdate>20150623</creationdate><title>USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA</title><author>ANDOR, GYOERGY ; LASZLOVSZKY, ISTVAN ; NEMETH, GYOERGY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2687521C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ANDOR, GYOERGY</creatorcontrib><creatorcontrib>LASZLOVSZKY, ISTVAN</creatorcontrib><creatorcontrib>NEMETH, GYOERGY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANDOR, GYOERGY</au><au>LASZLOVSZKY, ISTVAN</au><au>NEMETH, GYOERGY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA</title><date>2015-06-23</date><risdate>2015</risdate><abstract>The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof. La présente invention concerne l'utilisation de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique, dans la fabrication d'un médicament destiné au traitement de la schizophrénie. La présente invention concerne également le traitement de la schizophrénie par administration de dérivés (thio)-carbamoyl-cyclohexane, en particulier d'une trans-4- {2-[4-(2,3 -dichlorophényl)-pipérazin-1-yl] -éthyl} -N,N- diméthylcarbamoyl-cyclohexylamine et de leurs sels de qualité pharmaceutique.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2687521C
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING SCHIZOPHRENIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANDOR,%20GYOERGY&rft.date=2015-06-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2687521C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true